Next-generation deep sequencing improves detection of BCR-ABL1 kinase domain mutations emerging under tyrosine kinase inhibitor treatment of chronic myeloid leukemia patients in chronic phase.
Journal of cancer research and clinical oncology | 2015-05-01 | PMID 25367136
Machova Polakova Katerina, Kulvait Vojtech, Benesova Adela and 12 more
Genes: ABL1, BCR
